Skip to main content
    O

    Oric Pharmaceuticals Inc (ORIC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.52
    -0.34 (-4.33%)

    Market Cap: $814.71M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Oric Pharmaceuticals Inc (ORIC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Oric Pharmaceuticals (ORIC) to earn -$1.49 per share in the fiscal year ending Dec 31, 2026. Of 15 analysts, 14 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 15 ratings average 1.93, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 93% of the ratings.

    RatingAnalystsShare
    Strong Buy213.3%
    Buy1280.0%
    Hold16.7%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    15

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss.

    Fiscal year ending Dec 31, 2026
    -$1.49
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$1.69
    EPS consensus
    Next report
    Feb 22, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$1.49-$1.64 to -$1.2513
    Dec 31, 2027-$1.69-$1.98 to -$1.3713

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.41-$0.46 to -$0.3516

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 2 upward and 2 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202611
    Fiscal year ending Dec 31, 202711

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.47.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$1.49-$1.49-$1.48-$1.48-$1.47N/A
    Fiscal year ending Dec 31, 2027-$1.69-$1.67-$1.65-$1.61-$1.61N/A

    Frequently Asked Questions About ORIC

    What is the ORIC stock forecast?

    Consensus analyst estimates put Oric Pharmaceuticals's EPS at -$1.49 for the fiscal year ending Dec 31, 2026. The consensus rating from 15 analysts is Buy.

    How do analysts rate ORIC stock?

    Of 15 analysts covering Oric Pharmaceuticals, 2 rate it Strong Buy, 12 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from ORIC next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.49, with estimates from -$1.64 to -$1.25 from 13 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.69, with estimates from -$1.98 to -$1.37 from 13 analysts.

    How many analysts cover ORIC?

    15 analysts rate Oric Pharmaceuticals stock, and 13 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.